ProQR Therapeutics (PRQR) Long-Term Investments (2021 - 2023)
Historic Long-Term Investments for ProQR Therapeutics (PRQR) over the last 3 years, with Q2 2023 value amounting to $676222.0.
- ProQR Therapeutics' Long-Term Investments rose 204.93% to $676222.0 in Q2 2023 from the same period last year, while for Jun 2023 it was $676222.0, marking a year-over-year increase of 204.93%. This contributed to the annual value of $633573.6 for FY2022, which is 659231.79% up from last year.
- As of Q2 2023, ProQR Therapeutics' Long-Term Investments stood at $676222.0, which was up 204.93% from $666545.3 recorded in Q1 2023.
- Over the past 5 years, ProQR Therapeutics' Long-Term Investments peaked at $747852.6 during Q2 2021, and registered a low of $749.07 during Q1 2021.
- Moreover, its 3-year median value for Long-Term Investments was $664593.7 (2023), whereas its average is $545218.4.
- Examining YoY changes over the last 5 years, ProQR Therapeutics' Long-Term Investments showed a top increase of 9294461.27% in 2022 and a maximum decrease of 1450.14% in 2022.
- ProQR Therapeutics' Long-Term Investments (Quarter) stood at $9151.8 in 2021, then skyrocketed by 6822.96% to $633573.6 in 2022, then increased by 6.73% to $676222.0 in 2023.
- Its last three reported values are $676222.0 in Q2 2023, $666545.3 for Q1 2023, and $633573.6 during Q4 2022.